Cambridge biotech Oncorus to test cancer drug in humans after raising $80M

Oncorus is developing two treatments it hopes will alert the immune system to begin fighting cancer tumors, as well as teaching the system what to look for and fight next time.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.